John Harlow
Chief Commercial Officer
Bio:
John Harlow is Chief Commercial Officer at Melinta Therapeutics, where he has led the company’s transformation from an antibiotics-focused business to a leader in acute care. Since 2020, his leadership has driven 85% revenue growth, positive cash flow, and double-digit EBITDA growth, fueled by expanding the commercial team to 80+ people and guided by his “people first, performance always” philosophy. By investing in talent, cultivating individual strengths, and engaging his team in a shared, customer-centered mission, John has strengthened Melinta’s brand, created new value, and advanced business opportunities -- achievements instrumental in positioning the company for its acquisition by CorMedix in August 2025. Previously, he held senior roles at Baudax Bio, Recro Pharma, Endo Pharmaceuticals, and Novartis, where he led large teams, product launches, and turnarounds. He also serves on the Board of Advisors for BranchLab, a healthcare marketing AI startup.